8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hepatitis C
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04885855
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Muhammad Radzi Abu Hassan, FRCP Hospital Sultanah Bahiyah, Ministry of Health Malaysia